Literature DB >> 454962

Comparison of the autonomic effects of some currently-used neuromuscular blocking agents [proceedings].

R J Marshall, J A Ojewole.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 454962      PMCID： PMC2043823     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  5 in total

1.  Effects on non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats.

Authors:  R Hughes; D J Chapple
Journal:  Br J Anaesth       Date:  1976-02       Impact factor: 9.166

2.  The effect of pancuronium on myocardial contraction and catecholamine metabolism.

Authors:  A D Ivankovich; D J Miletich; R F Albrecht; B Zahed
Journal:  J Pharm Pharmacol       Date:  1975-11       Impact factor: 3.765

3.  The effect of disulfide bond reduction on the properties of cholinergic receptors in chick muscle.

Authors:  H P Rang; J M Ritter
Journal:  Mol Pharmacol       Date:  1971-11       Impact factor: 4.436

4.  Potentiation of cardiac sympathetic nerve responses in vivo by pancuronium bromide [proceedings].

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

5.  Studies on the repetitive discharges evoked in motor nerve and skeletal muscle after injection of anticholinesterase drugs.

Authors:  L C BLABER; W C BOWMAN
Journal:  Br J Pharmacol Chemother       Date:  1963-04
  5 in total
  5 in total

Review 1.  Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  M Abel; W J Book; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

2.  Three types of muscarinic receptors? [proceedings].

Authors:  R B Barlow; K N Burston; A Vis
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

3.  A comparison of the effects of pancuronium bromide and its monoquaternary analogue, ORG NC 45, on autonomic and somatic neurotransmission in the rat.

Authors:  J R Docherty; J C McGrath
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

4.  Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum.

Authors:  J Nedoma; N A Dorofeeva; S Tucek; S A Shelkovnikov; A F Danilov
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

5.  Determination of the muscarinic receptor subtype mediating vasodilatation.

Authors:  R M Eglen; R L Whiting
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.